Related references
Note: Only part of the references are listed.Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
Keith A. Wesnes et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Evidence-based treatment for opioid disorders: A 23-year national study of methadone dose levels
Thomas D'Aunno et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2014)
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Richard P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan
Ding-Lieh Liao et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Paul D. Brown et al.
NEURO-ONCOLOGY (2013)
Low-dose memantine-induced working memory improvement in the allothetic place avoidance alternation task (APAAT) in young adult male rats
Malgorzata J. Wesierska et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation
B. K. Bracken et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Low-Dose Memantine Attenuated Morphine Addictive Behavior Through its Anti-Inflammation and Neurotrophic Effects in Rats
Shiou-Lan Chen et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Opioid Metabolism
Howard S. Smith
MAYO CLINIC PROCEEDINGS (2012)
Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis
A. Baldacchino et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Memantine Affects Cognitive Flexibility in the Morris Water Maze
Bechara J. Saab et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study
Michael Soyka et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2011)
Cognitive function in short- and long-term substitution treatment: Are there differences?
Michael Soyka et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Identifying and treating cognitive impairment in bipolar disorder
Joseph F. Goldberg et al.
BIPOLAR DISORDERS (2009)
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Richard P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Cognitive Functioning During Methadone and Buprenorphine Treatment Results of a Randomized Clinical Trial
Michael Soyka et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
R. P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Memantine:: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system -: too little activation is bad, too much is even worse
Chris G. Parsons et al.
NEUROPHARMACOLOGY (2007)
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials
Harish Kavirajan et al.
LANCET NEUROLOGY (2007)
Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment
James Prosser et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Methadone maintenance improves cognitive performance after two months of treatment
Staci A. Gruber et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2006)
Profile of executive and memory function associated with amphetamine and opiate dependence
KD Ersche et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals
KD Ersche et al.
PSYCHOPHARMACOLOGY (2005)
Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers
A Verdejo et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Does executive dysfunction affect treatment outcome in late-life mood and anxiety disorders?
J Mohlman
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Opioid abuse and cognitive performance
MZ Mintzer et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments
MJ Kreek et al.
PHARMACOLOGICAL REVIEWS (2005)
Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence
SY Huang et al.
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice
BR Do Couto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
BA Brody et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex
RZ Goldstein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Neuropsychological deficits and opiate abuse
PE Davis et al.
DRUG AND ALCOHOL DEPENDENCE (2002)
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
LD Bradford
PHARMACOGENOMICS (2002)
Evaluation of memantine for neuroprotection in dementia
KK Jain
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Neurocognitive functioning of adolescents: Effects of protracted alcohol use
SA Brown et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2000)
Share Paper
